THROMBOGENICS N.V.;LIFE SCIENCES RESEARCH PARTNERS;VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW.
发明人:
申请号：
EP11160897.2
公开号：
EP2447281B1
申请日:
2006.03.24
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention provides novel monoclonal antibodies directed to PIGF and fragments and derivatives thereof, more particularly to humanized antibodies and fragments thereof for use in the treatment and/or prevention of pathological angiogenesis.
